NIFTY  8,943.75  0.05%
  SENSEX  28,919.20  0.09%
 CURRENCY  Rs  66.83/$ 70.65/€, 83.79/£
  GOLD  29,640.00  0.64%
  SILVER  43,310.00  1.06%
  DAX  11,804.00  -1.20%
  FTSE  7,243.70  -0.38%
  CAC  4,845.24  -0.79%
  HANG SENG  23,965.70  -0.62%
  NIKKEI  19,283.50  -0.45%
  Shanghai Composite  3,253.43  0.04%
  DOW JONES  20,821.80  0.06%
  NASDAQ  5,845.31  0.17%
  S&P 500  2,367.34  0.15%
STOCK ALERT : RIL Was Last At Rs 1250/Share In May 2009 STOCK ALERT : Reliance Market Capitalisation Crosses Rs 4 Lakh Cr

Cipla’s Pitch For Low-Cost Pharmaceuticals

Video:

Play this video

January 29: Cipla Chairman Y.K. Hamied shares his vision for the company and its journey over the years as a leader in pharma innovation. He discusses the company’s role in making medicines accessible and changing India’s reputation as a provider of low-cost alternatives to drugs. He discusses the creation of the anti-HIV Triomune drug and arriving at the game-changing recipe of success.